Neurology Endorsement Maintenance
Description
This measure identifies adults with migraines who are frequently taking acute (abortive) medications and are also taking a prophylactic medication for migraine control.
Description
This measure describes the change in functional communication status subsequent to speech-language pathology treatment of patients with memory deficits.
Description
This measure describes the change in functional communication status subsequent to speech-language pathology treatment of patients who exhibit deficits in speech-production.
Description
This measure describes the change in functional communication status subsequent to speech-language pathology treatment related to spoken language comprehension.
Description
This measure describes the change in functional communication status subsequent to speech-language pathology treatment related to spoken language expression.
Description
Number of stroke patients who make progress as defined by an increase of one or more levels on the Writing Functional Communication Measure (FCM).
Description
This measure describes the change in functional communication status subsequent to speech-language pathology treatment of patients who have attention deficits.
Description
This measure describes the change in functional communication status subsequent to speech-language pathology treatment of patients with reading disorders.
Description
This measure describes the change in functional communication status subsequent to speech-language pathology treatment of patients who exhibit difficuty in swallowing.
Description
Patient(s) with a recent emergency room encounter for a transient cerebral ischemic event that had any physician visit within 14 days of the acute event.